The patients with KRAS mutations at the Q61 site had on average 6.6 copies of the neoantigen present on each tumor cell surface, and the neoantigens flanking the G12 site had an average of 32.1 copies present per tumor cell. The gene discussed is KRAS; the disease is neoplasm.